PCN101 Budget IMPACT Analysis of Treatment-Free Remission (TFR) of Nilotinib Therapy in Chronic Myeloid Leukemia (CML) Patients in the Brazilian Private Healthcare System (BPHS)
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.238
https://www.valueinhealthjournal.com/article/S1098-3015(20)32494-3/fulltext
Title :
PCN101 Budget IMPACT Analysis of Treatment-Free Remission (TFR) of Nilotinib Therapy in Chronic Myeloid Leukemia (CML) Patients in the Brazilian Private Healthcare System (BPHS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32494-3&doi=10.1016/j.jval.2020.08.238
First page :
Section Title :
Open access? :
No
Section Order :
10187